{"DataElement":{"publicId":"2866951","version":"1","preferredName":"Recurrent Or Progressive Disease or Disorder Detection Chromosome Banding Fluorescence in situ Hybridization First Health Care Visit Date","preferredDefinition":"The return of a disease after a period of remission._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A disease process that is increasing in scope or severity._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The activity of perceiving, discerning, discovering or identifying._The treatment of chromosomes to reveal characteristic patterns of horizontal bands.  The banding patterns lend each chromosome a distinctive appearance so the 22 pairs of human nonsex chromosomes and the X and Y chromosomes can be identified and distinguished without ambiguity. Banding also permits the recognition of chromosome deletions (lost segments), chromosome duplications (surplus segments) and other types of structural rearrangements of chromosomes. (MedicineNet.com)_A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping._Preceding all others in time or space or degree._A visit by a patient or study participant to a medical professional._The date on which an observation was made or an event occurred.","longName":"R_O_P_D_O_D_D_C_B_F_","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2778149","version":"1","preferredName":"Recurrent Or Progressive Disease or Disorder Detection Chromosome Banding Fluorescence in situ Hybridization","preferredDefinition":"The return of a disease after a period of remission._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A disease process that is increasing in scope or severity._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The activity of perceiving, discerning, discovering or identifying._The treatment of chromosomes to reveal characteristic patterns of horizontal bands.  The banding patterns lend each chromosome a distinctive appearance so the 22 pairs of human nonsex chromosomes and the X and Y chromosomes can be identified and distinguished without ambiguity. Banding also permits the recognition of chromosome deletions (lost segments), chromosome duplications (surplus segments) and other types of structural rearrangements of chromosomes. (MedicineNet.com)_A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","longName":"RE_PR_DIS_DE_CB_FISH","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2778143","version":"1","preferredName":"Recurrent Disease Or PD Disease or Disorder","preferredDefinition":"the return of a sign, symptom, or disease after a remission.:Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Cancer that is increasing in scope or severity.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C38155:C37998:C35571:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5562E202-30BD-06CE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-26","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-08-26","modifiedBy":"ONEDATA","dateModified":"2008-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2778562","version":"1","preferredName":"Detection Chromosome Banding Fluorescence in situ Hybridization","preferredDefinition":"No value exists.:The treatment of chromosomes to reveal characteristic patterns of horizontal bands.  The banding patterns lend each chromosome a distinctive appearance so the 22 pairs of human nonsex chromosomes and the X and Y chromosomes can be identified and distinguished without ambiguity. Banding also permits the recognition of chromosome deletions (lost segments), chromosome duplications (surplus segments) and other types of structural rearrangements of chromosomes. (MedicineNet.com):A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","longName":"C16210:C16437:C17563","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chromosome Banding","conceptCode":"C16437","definition":"The treatment of chromosomes to reveal characteristic patterns of horizontal bands.  The banding patterns lend each chromosome a distinctive appearance so the 22 pairs of human non-sex chromosomes and the X and Y chromosomes can be identified and distinguished without ambiguity. Banding also permits the recognition of chromosome deletions (lost segments), chromosome duplications (surplus segments) and other types of structural rearrangements of chromosomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55744E27-D3FA-67C3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-08-27","modifiedBy":"ONEDATA","dateModified":"2008-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55641383-D685-0C1C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-26","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-08-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2769871","version":"1.1","preferredName":"First Health Care Visit Date","preferredDefinition":"Preceding all others in time or space or degree._A visit by a patient or study participant to a medical professional._the date on which an observation was made or an event occurred.","longName":"FST_HLTH_CR_VST_DT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"format":"YYYY-MM-DD","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2769870","version":"1","preferredName":"First Health Care Visit Date","preferredDefinition":"Preceding all others in time or space or degree.:A visit by a patient or study participant to a medical professional.:a particular day specified as the time something has, or will, happen.","longName":"C25509:C39564:C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Patient Visit","conceptCode":"C39564","definition":"A visit by a patient or study participant to a medical professional.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53A92558-DB00-6907-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-04","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-08-04","modifiedBy":"ONEDATA","dateModified":"2008-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68E1D59D-F860-F79F-E040-BB89AD4304C5","latestVersionIndicator":"Yes","beginDate":"2009-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-05-01","modifiedBy":"COOPERM","dateModified":"2009-05-01","changeDescription":"Versioned VD to change Short Name and Display Format. 5/1/09 mcooper","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964925","version":"1","longName":"2450r1: Post-TED","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"post_ted_prg_rlps_cyto_dt","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedObservation:dateRange","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"First date seen that detected","type":"Preferred Question Text","description":"First date seen that detected the relapse / progression by cytogenetic / FISH method:","url":null,"context":"NHLBI"},{"name":"Date first seen:","type":"Alternate Question Text","description":"Date first seen:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2866951","type":"BRIDG Mapping Path","description":"PerformedObservation.dateRange WHERE   PerformedObservation > PerformedDiagnosis.diseaseStatusCode = \"relapse\" OR \"progression\" AND PerformedDiagnosis > PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"Administer Hematapoietic Stem Cell Product {Transplantation}\" AND PerformedObservation.dateRange IS MINIMUM AND PerformedObservation.methodCode = \"FISH\" AND PerformedObservation > DefinedObservation.nameCode = \"assess disease status\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68E27676-CDFA-64B7-E040-BB89AD4362D3","latestVersionIndicator":"Yes","beginDate":"2009-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-05-01","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":". .1/8/14mn-added Bridg info.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}